New gene therapy cures 1st New Yorker of sickle cell anemia

Man Cured Of Sickle Cell Disease In New York Thanks To New Gene Therapy
NY resident Sebastien Beauzile was treated with a pioneering new gene therapy approach called Lyfgenia, curing his sickle cell anemia.
Long Island patient gets breakthrough sickle cell treatment called a ‘cure’: ‘I’m not in pain anymore’
He’s got new blood. A Long Island hospital said it administered life-changing Lyfgenia gene therapy treatment and successfully wiped away sickle cell disease from a Laurelton man. Cohen Children’s Medical Center said patient Sebastien Beauzile,
Sickle cell anemia patient reunites with Long Island doctors whose gene therapy treatments made him symptom-free
Sebastien Beauzile, 21, became the first person in New York state to be made symptom-free of sickle cell disease after undergoing Lyfgenia, a new type of gene therapy.
Man becomes first in New York to be cured of sickle cell
LONG ISLAND, NY (WCBS) - A 21-year-old man has become the first in New York to be cured of sickle cell anemia. “We feel blessed to be the first to be able to offer this,” said Dr. Jonathan Fish with the Cohen Children’s Medical Center.
Long Island man is first in New York history to be cured of sickle cell anemia
A patient on Long Island is the first in New York to be cured of sickle cell anemia, doctors say. They credit state-of-the-art genetic treatment. For 21 years, Sebastien Beauzile suffered chronic pain from debilitating sickle cell anemia.
Gene therapy cures man from sickle cell
A sickle cell gene therapy treatment has allowed a Long Island man to turn a chapter in his life. He was Sebastien Beauzile was born with sickle cell anemia and struggled to live a pain free life. However,
CNA1h
Ongoing R&D to reduce manufacturing costs of cell therapy treatments while ensuring quality
Singapore is using cell therapy to transform its cancer treatments. Doctors say it offers relapsed patients a 50 per cent ...
Multiple Sclerosis News Today17h
Patients on B-cell therapies less likely to stop treatment: Study
MS patients on anti-CD20 therapies are significantly less likely to discontinue treatment than those given other DMTs, a ...
Medindia12h
HIV Cure Closer? Scientists Discovers New Way to Trace Dormant HIV Cells
A new method is developed to track dormant HIV-infected cells. This breakthrough may lead to new treatments that eliminate ...
Managed Healthcare Executive2d
CAR T-Cell Therapy Cuts Costs, Reduces Treatment in Mantle Cell Lymphoma
In a real-world study, researchers found this data by comparing treatment patterns, healthcare resource utilization, and ...